YMTracker DRIPCalc v2 Launch sale

NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!

Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.

ASTH | NASDAQ

$37.71 -$0.16 | -0.42%

TREND SIGNAL: Signal available — unlock to view

Signal available — unlock to view

|2026-10-13

Add to favoritesFavorite

Company Overview:

Market Cap: $1.87B

Trailing PE: 46x

FWD PE *: 22.7x

Payout Ratio (TTM): —

52-Week Range: $18.08 - $51.60

* Forward PE is based on street estimates.

10 Year ASTH Performance Metrics:

Total Return (with DRIP): 898% (25.86% CAGR)

Total Return (no DRIP): 898% (25.86% CAGR)

Share Price: 898% (25.86% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $99,762

Total Return $ (with DRIP): $89,762

ASTH Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

ASTH Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

Most Popular

PREMIUM

$288 ($24/mo) $172.80/yr ($14.40/mo)

7-day free trial

Everything in Pro
YieldMax PNL Tracker
YieldMax NAV Erosion Alerts
YM ETFs Trend Signals
9/21 EMA Trend Signals
Stocks Dashboard

Try it free for 7 days

Combined 55% Lifetime Discount

ULTRA

$576 ($48/mo) $345.60/yr ($28.80/mo)

7-day free trial

Everything in Premium
15min & 1hr Intraday Signals
Group & weekly ETF estimates
YouTuber Mode
Trades summary + CSV export
Priority data & support

Try it free for 7 days

Combined 55% Lifetime Discount

ASTH Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

ASTH - Revenue

ASTH Revenue CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ASTH - Earnings Per Share (EPS)

ASTH EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ASTH - Net Income

🔓 See the full chart40% off right now · 7-day free trial

ASTH Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ASTH - EBITDA

🔓 See the full chart40% off right now · 7-day free trial

ASTH EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ASTH - Free Cash Flow

🔓 See the full chart40% off right now · 7-day free trial

ASTH Free Cash Flow CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ASTH - Free Cash Flow / Share

🔓 See the full chart40% off right now · 7-day free trial

ASTH Free Cash Flow / Share CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ASTH - Operating Income

🔓 See the full chart40% off right now · 7-day free trial

ASTH Operating Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ASTH - Gross Profit

🔓 See the full chart40% off right now · 7-day free trial

ASTH Gross Profit CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ASTH - Shares Outstanding

🔓 See the full chart40% off right now · 7-day free trial

ASTH Shares Outstanding CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ASTH - Share Buybacks

🔓 See the full chart40% off right now · 7-day free trial

ASTH Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ASTH - Stock-Based Comp

🔓 See the full chart40% off right now · 7-day free trial

ASTH Stock-Based Comp CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ASTH - Expenses

🔓 See the full chart40% off right now · 7-day free trial

ASTH Expenses CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ASTH - Revenue vs Net Income

🔓 See the full chart40% off right now · 7-day free trial

ASTH - EPS vs FCF / Share

🔓 See the full chart40% off right now · 7-day free trial

ASTH - EPS vs PE Ratio

🔓 See the full chart40% off right now · 7-day free trial

ASTH - FCF vs FCF / Share

🔓 See the full chart40% off right now · 7-day free trial

ASTH - FCF vs Stock Based Comp

🔓 See the full chart40% off right now · 7-day free trial

ASTH - Cash & Debt

🔓 See the full chart40% off right now · 7-day free trial

ASTH - Revenue by Segment

🔓 See the full chart40% off right now · 7-day free trial

ASTH Revenue CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

ASTH - REVENUE: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

ASTH Actual Revenue CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ASTH - EPS: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

ASTH Actual EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ASTH - NET INCOME: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

ASTH Actual Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ASTH - EBITDA: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

ASTH Actual EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

ASTH - Net Profit Margin

🔓 See the full chart40% off right now · 7-day free trial

ASTH Net Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ASTH - Gross Profit Margin

🔓 See the full chart40% off right now · 7-day free trial

ASTH Gross Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ASTH - Price to Earnings

🔓 See the full chart40% off right now · 7-day free trial

ASTH Price to Earnings CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ASTH - Price To Sales Ratio

🔓 See the full chart40% off right now · 7-day free trial

ASTH Price To Sales Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ASTH - Return on Capital Employed

🔓 See the full chart40% off right now · 7-day free trial

ASTH Return on Capital Employed CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

ASTH - Return on Invested Capital

🔓 See the full chart40% off right now · 7-day free trial

ASTH Return on Invested Capital CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Projected Future Returns & Dividends for ASTH

Based on past 10-year performance, here are ASTH growth metrics:

Share price CAGR of +25.86%
Dividend CAGR of +0%

Using ASTH CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	ASTH (DRIP)	ASTH - No DRIP
Current Price	$37.71	$37.71
Start Shares	265.18	265.18
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	265.18	265.18
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$37.71	$37.71
Total Dividends	$0	$0
Final Value	$10,000	$10,000

Estimated Future Value + Dividends - ASTH

NOTE: Above numbers are our estimate based on ASTH's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

Most Popular

PREMIUM

$288 ($24/mo) $172.80/yr ($14.40/mo)

7-day free trial

Everything in Pro
YieldMax PNL Tracker
YieldMax NAV Erosion Alerts
YM ETFs Trend Signals
9/21 EMA Trend Signals
Stocks Dashboard

Try it free for 7 days

Combined 55% Lifetime Discount

ULTRA

$576 ($48/mo) $345.60/yr ($28.80/mo)

7-day free trial

Everything in Premium
15min & 1hr Intraday Signals
Group & weekly ETF estimates
YouTuber Mode
Trades summary + CSV export
Priority data & support

Try it free for 7 days

Combined 55% Lifetime Discount

Company Info

Astrana Health Inc. (ASTH) had its IPO on , and is traded on NASDAQ stock exchange.

Astrana Health Inc. is a physician-centric healthcare management company that provides integrated medical care services in the United States. Its platform combines care coordination, population health management, and technology-enabled support to help physicians, specialists, hospitals, and health plans deliver coordinated, value-based care. The company operates through three main segments: Care Partners, Care Delivery, and Care Enablement. These businesses work together to support primary care, multi-specialty care, immediate care, radiology, laboratory services, and other clinical and administrative functions across its network. Astrana Health serves patients covered by public and private insurance, as well as uninsured patients, with a focus on improving care delivery across complex healthcare settings. Headquartered in Alhambra, California, Astrana Health plays a role in the healthcare services market by linking clinical operations with technology and risk-bearing care models.

ASTH website: https://www.astranahealth.com

Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

Most Popular

PREMIUM

$288 ($24/mo) $172.80/yr ($14.40/mo)

7-day free trial

Everything in Pro
YieldMax PNL Tracker
YieldMax NAV Erosion Alerts
YM ETFs Trend Signals
9/21 EMA Trend Signals
Stocks Dashboard

Try it free for 7 days

Combined 55% Lifetime Discount

ULTRA

$576 ($48/mo) $345.60/yr ($28.80/mo)

7-day free trial

Everything in Premium
15min & 1hr Intraday Signals
Group & weekly ETF estimates
YouTuber Mode
Trades summary + CSV export
Priority data & support

Try it free for 7 days

Combined 55% Lifetime Discount

Loading signals…

DCF Model — ASTH

Value from:

EPS (TTM)icompany profit per share over the last 12 months

EPS Growth %ihow fast profit per share grows each of the next 5 years — prefilled with what analysts expect

EPS growth after year 5 (forever)ithe slower pace once the fast 5 years are over — only drives years 6-10 of the price path below

Exit multiple (PE in 5 yrs)iwhat buyers pay per $1 of profit in 2031 — prefilled with today’s forward PE

Desired return %/yrithe yearly return you want from buying today — the S&P has done ~14%/yr, ask for more from a single stock

FCF growth %/yr (next 5 yrs)ihow fast free cash flow grows while the company is still expanding fast

Years of fast FCF growthihow many years the fast growth lasts before the business settles down

FCF growth after year 5 (forever)ithe slow, steady pace once the company is mature — usually 2-3%, near inflation. Must stay below your target return

Risk-free rate %iwhat a 10-yr US treasury pays with zero risk — the floor any risky stock must beat

Your target return %/yrithe yearly return you want for taking this risk — rule of thumb: risk-free rate + extra for risk

FCF base ($M, TTM)ilast 12 months of free cash flow, added up from reported quarters

Include dividends in returnidividends hand you part of the return in cash, so the share price needs to climb less

Pay up to today

—

vs current price $37.71

—

Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today

—

grows for the next years

Then mature

—

every future dollar counted back to today

Pile of today-dollars

—

÷ shares

Implied price path

Year	FCF	Implied price

Sensitivity — fair value: growth ↓ × target return →

× Free Portfolio Tracker

Own ASTH? See every dividend it's paid you

Add your ASTH shares to a free account and every payment you've received is listed — dated, in dollars — with reinvested shares counted and monthly totals. Room for 4 more stocks.

✓Every ASTH dividend you've received, dated, with the amount
✓Reinvested (DRIP) shares counted for you
✓Monthly totals across up to 5 stocks

See my ASTH payments →

Free plan · up to 5 holdings